Comments
U.S. top court rules for generic drugmaker on patent
18.04.2012. | WASHINGTON (Reuters) - The U.S. Supreme Court ruled on Tuesday in favor of a generic drugmaker in a case over how companies can fight brand-name rivals in an effort to get their cheaper medicines to market....
